Company Overview
| Stock Name | Cloudr |
|---|---|
| Stock Code | 09955 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們為醫院和藥店提供醫療用品和SaaS產品,為製藥公司提供數字營銷服務,為患者提供在線問診和處方開具,所有均圍繞著慢病管理。 |
| Listing Date | 2022-07-06 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市余杭區五常街道文一西路998號(海創園)4樓401、403及405(A)室 |
| Business Address (Hong Kong) | 香港皇后大道東183號合和中心54樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | cloudr.cn |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 30.50 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2022-06-23 to 2022-06-28 |
| Global Offering Shares | 19,000,000 shares |
| HK Public Offer Shares (Initial) | 1,900,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 17,100,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 587,038,219 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 61.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 579,500,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 384.9M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +2424% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 17,904,665,679 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | 不適用(公司處於虧損狀態) |
| Profit/Loss Status | 虧損人民幣4,153.2百萬元 |
| Period-End Cash Balance | 人民幣11億元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue | 524,438 | 839,123 | 1,756,731 |
| Cost of sales | -462,868 | -606,367 | -1,186,707 |
| Gross profit | 61,570 | 232,756 | 570,024 |
| Other income and gains, net | 4,765 | 5,732 | 29,916 |
| Selling and distribution expenses | -149,179 | -626,020 | -787,280 |
| Administrative expenses | -74,394 | -316,753 | -272,327 |
| Operating profit | -180,991 | -836,682 | -695,911 |
| Net finance costs | -57,802 | -57,802 | -61,962 |
| Profit before tax | -565,376 | -2,897,855 | -4,155,507 |
| Income tax expense | -13 | 966 | 2,314 |
| Profit for the year | -565,389 | -2,896,889 | -4,153,193 |
| Profit attributable to owners | -557,397 | -2,866,975 | -4,138,913 |
Balance Sheet
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Cash and cash equivalents | 601,164 | 914,226 | 1,090,575 |
| Trade and bills receivables | 159,159 | 298,545 | 497,266 |
| Inventories | 141,968 | 59,405 | 110,924 |
| Total current assets | 1,126,115 | 1,532,547 | 2,281,732 |
| Total assets | 1,162,102 | 1,687,342 | 2,508,153 |
| Total current liabilities | 2,032,220 | 5,067,748 | 9,644,125 |
| Total liabilities | 2,033,924 | 5,080,560 | 9,663,284 |
| Total equity | -871,822 | -3,393,218 | -7,155,131 |
| Equity attributable to owners | -854,618 | -3,361,921 | -7,137,952 |
| Interest-bearing borrowings | 83,900 | 203,511 | 114,383 |
Cash Flow Statement
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Net cash from operating activities | -360,335 | -438,465 | -666,333 |
| Net cash from investing activities | 3,405 | -160,196 | -155,497 |
| Net cash from financing activities | 813,589 | 918,406 | 1,015,371 |
| Net increase in cash | 456,659 | 319,745 | 193,541 |
| Depreciation of PP&E | 2,975 | 7,076 | 15,409 |
| Amortisation of intangible assets | 6,377 | 27,977 | 71,132 |
| Purchase of PP&E | -4,246 | -40,529 | -88,683 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 28.2 |
|---|---|
| First Day Open | HK$ 30.5 |
| First Day Change | -7.54% |
| First Day Volume | 4275800.0 |
| First Day Turnover | 119515000.0 |
| Use of Proceeds | 1、約60%預計將用于業務擴張,在全國范圍內擴大我們的醫院網絡;
2、約25%預計將用于提高我們的醫學知識和技術能力,以加強我們在數字醫療行業的領導地位;
3、約5%預計將用于通過戰略伙伴關系、投資和收購其他業務來擴大我們的生態系統,以補充我們的有機成長戰略;
4、約10%預計將用于營運資金和一般公司用途。 |
Underwriting Syndicate
Joint Sponsors (2)
Overall Coordinators (4)
Joint Bookrunners (5)
Joint Lead Managers (5)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Harvest International Premium Value (Secondary Market) Fund SPC | 156,998,750 HKD | — | 27.09% | — | 6 months | 2023-01-06 |
| 2 | Sanofi Foreign Participations B.V | 117,748,300 HKD | — | 20.32% | — | 6 months | 2023-01-06 |
| 3 | Tasly International Capital Limited | 39,247,400 HKD | — | 6.77% | — | 6 months | 2023-01-06 |
| 4 | 扬子江(香港)有限公司 | 39,247,400 HKD | — | 6.77% | — | 6 months | 2023-01-06 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 匡明 | — |
| Company Secretary | 劉夢雅 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 匡明先生(透過HaoYuan health Limited及表決權協議)控制約21.88%表決權;HaoYuan health Limited持股15.23%;Prime Forest Assets Limited持股12.49% |
|---|




